IRIS
Fasulo, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.816
NA - Nord America 1.362
SA - Sud America 442
EU - Europa 387
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 36
OC - Oceania 5
Totale 4.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.303
SG - Singapore 1.016
BR - Brasile 358
CN - Cina 358
VN - Vietnam 218
IT - Italia 138
HK - Hong Kong 64
AR - Argentina 41
FI - Finlandia 40
DE - Germania 39
FR - Francia 31
IN - India 31
IE - Irlanda 29
GB - Regno Unito 24
CA - Canada 22
BD - Bangladesh 20
ID - Indonesia 17
MX - Messico 14
TR - Turchia 14
IQ - Iraq 13
NG - Nigeria 13
JP - Giappone 11
NL - Olanda 11
PY - Paraguay 10
RU - Federazione Russa 10
EC - Ecuador 9
SE - Svezia 9
MO - Macao, regione amministrativa speciale della Cina 8
CO - Colombia 7
PK - Pakistan 7
PL - Polonia 7
VE - Venezuela 7
ZA - Sudafrica 7
AT - Austria 6
ES - Italia 6
UA - Ucraina 6
AU - Australia 5
EE - Estonia 5
MY - Malesia 5
UZ - Uzbekistan 5
BE - Belgio 4
CH - Svizzera 4
CL - Cile 4
HN - Honduras 4
AL - Albania 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
SA - Arabia Saudita 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GD - Grenada 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.049
Salva come PNG Salva come JPEG
Città #
Singapore 357
Ashburn 176
The Dalles 127
Beijing 118
San Jose 118
Dallas 77
Council Bluffs 75
Ho Chi Minh City 69
Milan 66
Shanghai 60
New York 58
Hanoi 52
Hong Kong 52
Chandler 48
Helsinki 40
Santa Clara 40
Los Angeles 32
Wilmington 31
Dublin 29
Boardman 19
Princeton 19
São Paulo 19
Ann Arbor 18
Buffalo 18
San Mateo 18
Paris 17
Brooklyn 16
Haiphong 16
Lawrence 15
Benin City 13
Da Nang 12
Rio de Janeiro 12
Rome 12
Chicago 10
Brasília 9
Naples 9
Orem 9
Amsterdam 8
Boston 8
London 8
Phoenix 8
Philadelphia 7
Seattle 7
Toronto 7
Warsaw 7
Buenos Aires 6
Hải Dương 6
Leawood 6
New Delhi 6
Tokyo 6
Curitiba 5
Fairfield 5
Johannesburg 5
Mexico City 5
Nuremberg 5
Osasco 5
Porto Alegre 5
Sacramento 5
Surabaya 5
Turin 5
Asunción 4
Cleveland 4
Falkenstein 4
Frankfurt am Main 4
Guarulhos 4
Ha Long 4
Istanbul 4
Joinville 4
Juiz de Fora 4
Kuala Lumpur 4
Laurinburg 4
Manaus 4
Manchester 4
Montreal 4
Mumbai 4
Pune 4
Ribeirão Preto 4
Salvador 4
São José do Rio Preto 4
Tashkent 4
Amman 3
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Brescia 3
Brussels 3
Campinas 3
Can Tho 3
Charlotte 3
Chennai 3
Cincinnati 3
City of London 3
Córdoba 3
Erbil 3
Fortaleza 3
Guangzhou 3
La Grange 3
Laredo 3
Las Vegas 3
Lawrenceville 3
Totale 2.166
Salva come PNG Salva come JPEG
Nome #
Clinical and pathological predictors of persistent T1 HG at second resection 123
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 114
Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken 114
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 114
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 96
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 93
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 92
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 90
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 90
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 90
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 89
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 86
Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer 82
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage 78
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 78
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study 77
Effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy: A randomized controlled trial 75
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience 75
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer 75
External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era 71
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging 69
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 65
Hope for Ostomates: A Carbon and Zeolite Impregnated Polyester Fabric Inhibits Urine Odor in Cancer Patients: A Randomized Experimental Study 64
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story 64
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? 64
Gender-specific risk factors for renal cell carcinoma: a systematic review 63
Is testis sparing surgery safe in patients with incidental small testicular lesions referring to a fertility center? A retrospective analysis reporting factors correlated to malignancy and long-term oncological outcomes 59
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure 57
Preliminary findings on vitamin D 25‐OH levels in urine analysis: implications for clinical practice 57
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer 56
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study 55
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial 54
Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study 53
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes 53
Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer 52
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis 51
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy 51
Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy 50
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 50
Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients 50
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis 49
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancer 48
A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer 48
Re: Stefano Fanti, Alberto Briganti, Louise Emmett, et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022;5:530-6: Extended Use of PSMA PET/CT in Candidates for Focal Therapy 47
Letter: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer 46
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center 46
Re: A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study 46
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension 45
Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment? 45
The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature 44
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 44
Clinical Utility of 4Kscore ®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer 44
Machine learning driven diagnostic pathway for clinically significant prostate cancer: the role of micro-ultrasound 43
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy 43
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data 42
Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer 42
Eve's and Adam's rib for prostate cancer screening 39
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis 38
Inter-reader Agreement for Prostate Cancer Detection Using Micro-ultrasound: A Multi-institutional Study 37
Prostate specific membrane antigen focal ablation imaging (PSMA-FAB) 36
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer 36
Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma 34
Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection 32
The Evaluation of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Initial Staging in Intermediate-Risk Prostate Cancer Patients: A Retrospective Multicenter Analysis 30
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance—Does Cancer Vanish or Simply Hide? 26
Exploring the metastatic potential of isolated tumour cells and clusters-cords patterns of ISUP Grade 5 acinar adenocarcinoma of the prostate: a comprehensive morphological analysis 26
ProMUS-NET: Artificial intelligence detects more prostate cancer than urologists on micro-ultrasonography 26
Robotic Surgery and Patient Safety: A Global Assessment of Technological Malfunctions During da Vinci X and Xi Procedures 25
GPT-4 generates accurate and readable patient education materials aligned with current oncological guidelines: A randomized assessment 21
The role of primary tumour site surgery in metastatic UTUC : a systematic review and meta‐analysis 21
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures 20
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications 13
[68Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX) 11
Totale 4.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202270 0 4 1 12 0 1 5 8 9 6 21 3
2022/2023194 32 4 18 19 18 11 8 12 24 23 21 4
2023/2024202 14 21 38 11 7 30 13 16 4 7 15 26
2024/2025839 5 2 21 14 6 55 39 33 67 145 169 283
2025/20262.417 279 226 156 298 129 111 406 138 171 199 156 148
2026/2027329 186 143 0 0 0 0 0 0 0 0 0 0
Totale 4.132